Growth hormone deficiency (GHD) related to standard dose chemotherapy has rarely been
described. We report on a case of localized ganglioneuroblastoma treated by …

Background. Chemotherapy (CT) may produce growth impairment, however, the
pathogenesis is still unclear. Methods. A series of 25 patients mean age 13.3 years (6.3 …

Roman et all found growth hormone deficiency (GHD) in half of the inpatients with cancer
treated with chemotherapy. Thirty months after treatment, patients with GHD grew only …

Methods: We studied the prevalence of SNs in 49 CCS who developed GDH during
childhood, after cancer therapy. 32 patient had a previous diagnosis of central nervous …

Ganglioneuromas are slow-growing benign counterparts of neuroblastoma groups along
with ganglioneuroblastomas. Herein, we report a rare case of hormone-secreting benign …

We sought to determine the cause of short stature in a 9-year-old girl who was referred to the
University of Texas MD Anderson Cancer Center for evaluation of this condition. At 4 years …

Growth hormone deficiency (GHD) is a recognized late effect of successful treatment of
tumors requiring cranial irradiation. Growth after treatment was assessed in 16 patients with …

A 10-year-old girl with multiple persistent ganglioneuromas originating from the
spontaneous maturation of a metastatic neuroblastoma is described. Multiple biopsies …

Optic pathway gliomas (OPGs) are low-grade tumors often arising in the context of
Neurofibromatosis 1 (NF1). NF1 can be associated with a dysre-gulation of Growth Hormone …

Purpose: This report describes a female infant with stage 4 multifocal ganglioneuroblastoma
with gastric involvement. Patient: The patient had a right cervical tumor, a left posterior …